Why the study?
Renin drives renal artery stenosis, but the role of the transcription factor Sox6 in controlling renal renin during renal artery stenosis was unknown.
Does Sox6 knockout in renin-expressing cells prevent renovascular hypertension and kidney injury in a mouse model of renal artery stenosis?
Does Sox6 knockout in renin-expressing cells prevent renovascular hypertension and kidney injury in a mouse model of renal artery stenosis?
Knocking out the transcription factor Sox6 in renin-expressing cells protects mice against renovascular hypertension and kidney injury induced by renal artery stenosis.
Sox6 may represent a renin-regulatory target in renovascular hypertension models; leaves open any therapeutic role in human renal artery stenosis.
Key Points Sox6 controls the increased renin expression that is induced during renal artery stenosis, and thus has a novel function in renovascular hypertension. Sox6 knockout in Ren1d+ cells inhibited the renovascular hypertension and kidney injury induced by renal artery stenosis. The results presented in this manuscript point to a new transcriptional regulatory network in renal artery stenosis which is controlled by Sox6. Background Renal artery stenosis (RAStenosis) or renal artery occlusion is an intractable problem affecting about 6% of people >65 and up to 40% of people with coronary or peripheral vascular disease in the Unites States. The renal renin-angiotensin-aldosterone system plays a key role in RAStenosis, with renin (which is mainly produced in the kidney) being recognized as the driver of the disease. In this study, we will determine a new function for the transcription factor Sox6 in the control of renal renin during RAStenosis. Methods We hypothesize that knocking out Sox6 in Ren1d-positive cells will protect mice against renovascular hypertension and kidney injury. To test our hypothesis, we used a new transgenic mouse model, Ren1d cre /Sox6 fl/fl (Sox6 KO), in which Sox6 is knocked out in renin-expressing cells. We used a modified two-kidney, one-clip (2K1C) Goldblatt mouse model to induce RAStenosis and renovascular hypertension. BP was measured using the tail-cuff method. Renin, prorenin, Sox6, and NGAL expressions levels were measured with Western blot, in situ hybridization, and immunohistochemistry. Creatinine levels were measured using the colorimetric assay. Results Systolic BP was significantly lower in Sox6 KO 2 weeks after RAStenosis compared with Sox6 WT (Ren1d cre /Sox6 wt/wt ). Renin, prorenin, and NGAL expression levels in the stenosed kidney were lower in Sox6 KO compared with Sox6 WT mice. Furthermore, creatinine clearance was preserved in Sox6 KO compared with Sox6 WT mice. Conclusions Our data indicate that Sox6 controls renal renin and prorenin expression and, as such, has a function in renovascular hypertension induced by RAStenosis. These results point to a novel transcriptional regulatory network controlled by Sox6.
No takes yet. Share an insight, caveat, or question.
Saleem et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: